Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (53) Iamin, ProCyte,
...of Action Topically-applied Iamin gel wound dressing contains a naturally occurring tripeptide complexed with copper. Copper is known to play a vital role in the action of certain enzymes in the ...
View Page

2.  CenterWatch Clinical Research Profile (5297) Trial #2171, DCOL Center for Clinical Research, Longview, TX
...Research, Longview, TX Research Center Profile: DCOL Center for Clinical Research Contact Info Sharon A. Coppinger, CCRC Clinic Supervisor DCOL Center for Clinical Research 707 Hollybrook Drive, Suite 501 Longview, TX ...
...information please have your colleagues visit our website @ www.dcolresearch.com or contact Sharon A. Coppinger, CCRC, Clinic Supervisor via email @ scoppinger@dcolresearch.com . Clinical Research Experience Experience Summary: DCOL Center ...
View Page

3.  Newly Approved Drug Therapies (223) Galzin (zinc acetate), Teva Pharmaceutical,
...a potentially fatal inherited abnormality, occurring in one of 30,000 people, that causes excess copper to accumulate in the body, affecting the liver and the brain. Patients become ill as ...
...young adults with liver disease, often with neurologic symptoms. Galzin works by blocking absorption of copper from the intestine. Jobson Medical Information • Privacy | • Glossary Copyright © 1995-2010 Jobson Medical Information LLC ...
View Page

4.  Study Posting (77) Trial #154658, Acute Myelogenous Leukemia (AML), Lake Success, NY
...infection • Allergy to cytarabine, daunorubicin or liposomal products • History of Wilson’s disease or other copper-related disorder Marjorie Fricano, Study Coordinator Biomedical Research Alliance of New York Monter Cancer Center ...
View Page

5.  Study Posting (77) Trial #162676, Acute Myelogenous Leukemia (AML), Bronx, NY
...infection • Allergy to cytarabine, daunorubicin or liposomal products • History of Wilson’s disease or other copper-related disorder Kimcita Vargas-Walker, Study Coordinator Biomedical Research Alliance of New York Montefiore Medical ...
View Page

6.  Study Posting (77) Trial #142201, Acute Myelogenous Leukemia (AML), Lake Success, NY
...infection • Hypersensitivity to cytarabine, daunorubicin or liposomal products • History of Wilson's disease or other copper-related disorder • Have participated in another research study within the last 30 days Marjorie Fricano ...
View Page

7.  CenterWatch: New Medical Therapies in Disease Category (336), Chronic Fatigue Syndrome
...of an open-label extension of a phase II study of PBT-1 (clioquinol) , a copper-zinc attenuator/amyloid-beta aggregation inhibitor for the treatment of Alzheimer’s disease (AD ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (100), Migraine and Cluster Headaches
...of an open-label extension of a phase II study of PBT-1 (clioquinol) , a copper-zinc attenuator/amyloid-beta aggregation inhibitor for the treatment of Alzheimer’s disease (AD ...
View Page

9.  CenterWatch: New Medical Therapies in Disease Category (11), Alzheimer's Disease
...of an open-label extension of a phase II study of PBT-1 (clioquinol) , a copper-zinc attenuator/amyloid-beta aggregation inhibitor for the treatment of Alzheimer’s disease (AD ...
View Page

10. RP96cover.qxp
...since the 1940s to treat heavy metal poisoning from compounds such as lead, mercury, and copper. EDTA binds to these metals and creates a new compound that can be excreted in ...
View Page